Radiofrequency ablation versus hepatic resection for small hepatocellular carcinomas: A meta-analysis of randomized and nonrandomized controlled trials

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Wang, Yingqiang ^a,b   Luo, Qianqian ^a   Li, Youping ^a   Deng, Shaolin ^a   Wei, Shiyou ^a   Li, Xianglian ^a  

^a SICHUAN UNIVERSITY   (China)

^b Aviation Industry of China   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER PROGNOSIS; CLINICAL EFFECTIVENESS; DISEASE FREE SURVIVAL; EARLY CANCER; HUMAN; LENGTH OF STAY; LIVER CELL CARCINOMA; LIVER RESECTION; META ANALYSIS; MORTALITY; OVERALL SURVIVAL; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE FREE SURVIVAL; RECURRENCE RISK; TUMOR RECURRENCE; TUMOR VOLUME;

CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CONTROLLED CLINICAL TRIALS AS TOPIC; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; ODDS RATIO; PUBLICATION BIAS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84896778247     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084484     Document Type: Article

References (50)

1. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, et al. (2012) Disabilityadjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859): 2197-2223.
2. Soerjomataram I, Lortet-Tieulent J, Parkin DM, Ferlay J, Mathers C, et al. (2012) Global burden of cancer in 2008: a systematic analysis of disabilityadjusted life-years in 12 world regions. Lancet 380(9856):1840-1850.
3. Bray F, Jemal A, Grey N, Ferlay J, Forman D (2012) Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol 13: 790-801.
4. Llovet JM, Lencioni R, Di Bisceglie AM, Gaile PR, Dufour JF, et al. (2012) EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol 56: 908-943.
5. Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53: 1020-1022.
6. Kobayashi M, Ikeda K, Kawamura Y, Yatsuji H, Hosaka T, et al. (2009) High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma. Cancer 115: 571-580.
7. Wang YQ, Luo QQ, L YP, Deng SL, Li XL, et al. (2013) A Systematic Assessment of the Quality of Systematic Reviews/Meta-analyses in Radiofrequency Ablation versus Hepatic Resection for Small Hepatocellular Carcinoma. J Evid Based Med.in press.
8. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6: e1000097.
9. U.S. Department of Health and Human Services. (2007) Guidance for industry clinical trial endpoints for the approval of cancer drugs and biologics. Food and Drug Adimistration Rockville. Available: from:http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM071590.pdf.
10. Huang J, Yan L, Cheng Z, Wu H, Du L, et al. (2010) A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg 252: 903-912.
11. Higgins JP, Green S (2011) Conchrane Handbook for Systematic Reviews of Interventions 5.1.0[updated March 2011]. The Cochrane Collaboration. Available: from:www.cochrane-handbook.org.
12. Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, et al. (2003) Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 73: 712-716. (Pubitemid 37267119)
13. Feng K, Yan J, Li X, Xia F, Ma K, et al. (2012) A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol 57: 794-802.
14. Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, et al. (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243: 321-328. (Pubitemid 43327762)
15. Wang JH, Wang CC, Hung CH, Chen CL, Lu SN (2012) Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma. J Hepatol 56: 412-418.
16. Peng ZW, Lin XJ, Zhang YJ, Liang HH, Guo RP, et al. (2012) Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study. Radiology 262: 1022-1033.
17. Liu H, Hu JF, Weng HF, Feng LL, Cao H (2011) Effect and safety of radiofrequency catheter ablation for single small hepatocellular carcinoma[Article in Chinese]. Pracitical Clinical Medicine 12(11): 16-18.
18. Fu J, Chen Y, Lei TJ, Li HM, Lei HL, et al. (2011) Comparison of curative effect between radiofrequency ablation and surgical resection in treatment of elderly patients with small hepatocellular carcinoma[Article in Chinese]. Journal of Jilin University(Medicine Edition) 37(4): 733-737.
19. Kong WT, Zhang WW, Qiu YD, Zhou T, Bin H (2011) Prospective comparative study of cool-tip radiofrequency ablation and surgical resection for hepatocellular carcinoma. Chinese-German J Clin Oncol 10(7): 399-405.
20. Nishikawa H, Inuzuka T, Takeda H, Nakajima J, Matsuda F, et al. (2011) Comparison of percutaneous radiofrequency thermal ablation and surgical resection for small hepatocellular carcinoma. BMC Gastroenterol 11: 143.
21. Ikeda K, Kobayashi M, Kawamura Y, Imai N, Seko Y, et al. (2011) Stage progression of small hepatocellular carcinoma after radical therapy: comparisons of radiofrequency ablation and surgery using the Markov model. Liver Int 31: 692-699.
22. Hung HH, Chiou YY, Hsia CY, Su CW, Chou YH, et al. (2011) Survival rates are comparable after radiofrequency ablation or surgery in patients with small hepatocellular carcinomas. Clin Gastroenterol Hepatol 9: 79-86.
23. Huang J, Hernandez-Alejandro R, Croome KP, Yan L, Wu H, et al. (2011) Radiofrequency ablation versus surgical resection for hepatocellular carcinoma in Childs A cirrhotics-a retrospective study of 1,061 cases. J Gastrointest Surg 15: 311-320.
24. Guo WX, Zhai B, Lai EC, Li N, Shi J, et al. (2010) Percutaneous radiofrequency ablation versus partial hepatectomy for multicentric small hepatocellular carcinomas: a nonrandomized comparative study. World J Surg 34: 2671-2676.
25. Bu XY, Wang Y, Ge Z, Wang ZC, Zhang DS (2009) Comparison of radiofrequency ablation and surgical resection for small primary liver carcinoma[Article in Chinese]. Chin Arch Gen Surg (Electronic Edition). 3(2):127-131.
26. Ueno S, Sakoda M, Kubo F, Hiwatashi K, Tateno T, et al. (2009) Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria. J Hepatobiliary Pancreat Surg 16: 359-366.
27. Santambrogio R, Opocher E, Zuin M, Selmi C, Bertolini E, et al. (2009) Surgical resection versus laparoscopic radiofrequency ablation in patients with hepatocellular carcinoma and Child-Pugh class a liver cirrhosis. Ann Surg Oncol 16: 3289-3298.
28. Hiraoka A, Horiike N, Yamashita Y, Koizumi Y, Doi K, et al. (2008) Efficacy of radiofrequency ablation therapy compared to surgical resection in 164 patients in Japan with single hepatocellular carcinoma smaller than 3 cm, along with report of complications. Hepatogastroenterology 55: 2171-2174.
29. Hasegawa K, Makuuchi M, Takayama T, Kokudo N, Arii S, et al. (2008) Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol 49: 589-594.
30. Guglielmi A, Ruzzenente A, Valdegamberi A, Pachera S, Campagnaro T, et al. (2008) Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis. J Gastrointest Surg 12: 192-198.
31. Abu-Hilal M, Primrose JN, Casaril A, McPhail MJ, Pearce NW, et al. (2008) Surgical resection versus radiofrequency ablation in the treatment of small unifocal hepatocellular carcinoma. J Gastrointest Surg 12: 1521-1526.
32. Zhou T, Qiu YD, Kong WT, Zhang WW, Ding YT (2007) Comparison the effect of radiofrequency ablation and surgical resection for the treatment of small hepatocellular carcinoma[Article in Chinese]. Journal of hepatobiliary surgery 15(6): 424-427.
33. Gao W, Chen MH, Yan K, Yang W, Sun Y, et al. (2007) Therapeutic effect of radiofrequency ablation in unsuitable operative small hepatocellular carcinoma[ Article in Chinese]. Chin J Med Imaging Technol 23(2):254-257
34. Lupo L, Panzera P, Giannelli G, Memeo M, Gentile A, et al. (2007) Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? HPB (Oxford) 9: 429-434. (Pubitemid 350215037)
35. Montorsi M, Santambrogio R, Bianchi P, Donadon M, Moroni E, et al. (2005) Survival and recurrences after hepatic resection or radiofrequency for hepatocellular carcinoma in cirrhotic patients: a multivariate analysis. J Gastrointest Surg 9: 62-67; discussion 67-68.
36. Hong SN, Lee SY, Choi MS, Lee JH, Koh KC, et al. (2005) Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol 39: 247-252.
37. Cho CM, Tak WY, Kweon YO, Kim SK, Choi YH, et al. (2005) [The comparative results of radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma]. Korean J Hepatol 11: 59-71.
38. Vivarelli M, Guglielmi A, Ruzzenente A, Cucchetti A, Bellusci R, et al. (2004) Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 240: 102-107. (Pubitemid 38808241)
39. Gravante G, Overton J, Sorge R, Bhardwaj N, Metcalfe MS, et al. (2011) Radiofrequency ablation versus resection for liver tumours: an evidence-based approach to retrospective comparative studies. J Gastrointest Surg 15: 378-387.
40. Xie XQ, Dendukuri N, McGregor M (2010) Percutaneous radiofrequency ablation for the treatment of early stage hepatocellular carcinoma: A health technology assessment. Int J Technol Assess Health Care 26: 390-397.
41. Liu JG, Wang YJ, Du Z (2010) Radiofrequency ablation in the treatment of small hepatocellular carcinoma: a meta analysis. World J Gastroenterol 16: 3450-3456.
42. Li L, Zhang JL, Liu XH, Li XH, Jiao BP, et al. (2012) Clinical outcomes of radiofrequency ablation and surgical resection for small hepatocellular carcinoma: A meta-analysis. J Gastroenterol Hepatol 27: 51-58.
43. Xu G, Qi FZ, Zhang JH, Cheng GF, Cai Y, et al. (2012) Meta-analysis of surgical resection and radiofrequency ablation for early hepatocellular carcinoma. World J Surg Oncol 10: 163.
44. Zytoon AA, Ishii H, Murakami K, El-Kholy MR, Furuse J, et al. (2007) Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome. Jpn J Clin Oncol 37: 658-672. (Pubitemid 47617785)
45. Park SK, Jung YK, Chung DH, Kim KK, Park YH, et al. (2013) Factors influencing hepatocellular carcinoma prognosis after hepatectomy: a singlecenter experience. Korean J Intern Med 28: 428-438.
46. Minami Y, Kudo M (2011) Radiofrequency ablation of hepatocellular carcinoma: a literature review. Int J Hepatol 2011: 104685.
47. Takahashi S, Kudo M, Chung H, Inoue T, Ishikawa E, et al. (2007) Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy. Oncology 72 Suppl 1: 98-103. (Pubitemid 350256672)
48. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, et al. (2008) What is "quality of evidence" and why is it important to clinicians? BMJ 336: 995-998. (Pubitemid 351656090)
49. Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, et al. (2011) GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 64: 401-406.
50. Guyatt GH, Oxman AD, Sultan S, Glasziou P, Akl EA, et al. (2011) GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol 64: 1311-1316.